Delivery Order SPE2DX22D0010-SPE2D825FFZ27
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,843.64 with firm fixed pricing and is scheduled for completion by September 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $4,442.48, is scheduled for completion by October 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Nucynta 75 mg tablets (100-count units) valued at $30,223.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,315.96 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg, a pain management pharmaceutical. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,234.27 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, for the supply of Nucynta ER Tabs 150mg. This competitive, non-set-aside contract has a ceiling value of $6,849.48 and is structured as a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The award is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $13,932.13 for Nucynta Tabs 75mg, a pain management pharmaceutical product. This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. The contract ceiling value is $5,313.94, with an ultimate completion date of October 1, 2025. This is a non-set-aside award issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FFZ27Delivery Order
The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Nucynta ER Tabs 250mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order, valued at $8,619.04 with an ultimate completion date of June 2, 2025, represents a non-competitive award executed under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with Defense Logistics Agency Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. AmerisourceBergen's status as a major pharmaceutical distributor and critical federal medical procurement vendor positions it to fulfill the Defense Health Agency's pharmaceutical requirements across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/30/25 |